Ovid Therapeutics Inc. (OVID)
undefined
undefined%
At close: undefined
1.04
1.05%
After-hours Dec 13, 2024, 04:31 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -52.34M -54.17M 122.83M -81.04M -60.46M -51.98M -64.81M -22.41M -13.16M -446.89K
Depreciation & Amortization 1.60M 1.38M 237.08K 306.85K 255.00K 141.73K 80.31K 56.51K 11.78K 2.31K
Stock-Based Compensation 7.29M 6.56M 5.05M 7.53M 5.21M 7.06M 6.40M 3.64M 1.46M 33.09K
Other Working Capital 635.51K -3.06M -18.52M 19.49M 4.59M -2.44M -79.50K 727.78K 1.22M 44.69K
Other Non-Cash Items -4.71M -764.94K 7.30M -199.41K -29.63K -1.24K 25.86M 3.64M 4.39M 105.52K
Deferred Income Tax - - - - - 4.61K - -3.64M - -
Change in Working Capital 2.39M -8.23M -16.81M 21.82M 3.94M -787.91K 996.85K 914.40K 1.81M 44.69K
Operating Cash Flow -45.78M -55.23M 118.61M -51.58M -51.09M -45.56M -31.47M -17.80M -5.49M -261.28K
Capital Expenditures -137.46K -1.42M -189.41K -390.68K -244.04K -352.02K -47.39K -188.99K -56.33K -1.78K
Acquisitions - -2.50M -1.63M 263.44K 186.89K 318.15K - - - -
Purchase of Investments -112.44M -172.96M -1.63B -9.96M -34.80M -50.01M - - - -
Sales Maturities Of Investments 120.00M 90.00M 1.64B 45.00M 5.00M 45.00M - - - -
Other Investing Acitivies -10.10M -1.00M -5.40M -263.44K -186.89K -318.15K -8.48K -158.62K -24.25K -4.33K
Investing Cash Flow -2.58M -87.88M -1.82M 34.65M -30.04M -5.36M -47.39K -188.99K -56.33K -6.12K
Debt Repayment - - - - - - - - - -
Common Stock Repurchased - - - - - - - - - -
Dividend Paid - - - - - - - - - -
Other Financial Acitivies 30.54M 180.66K 904.08K 341.04K 131.90K 286.14K -3.05M -13.67K 70.64M 6.73M
Financial Cash Flow 30.54M 180.66K 904.08K 47.07M 86.54M 286.14K 66.70M -13.67K 70.64M 6.73M
Net Cash Flow -17.83M -142.93M 117.69M 30.14M 5.41M -50.64M 35.19M -18.00M 65.10M 6.46M
Free Cash Flow -45.92M -56.65M 118.42M -51.97M -51.33M -45.91M -31.52M -17.99M -5.54M -263.06K